title: [Anti-PCSK9 in coronary artery disease: genetic progress, therapeutic approaches].
authors.forename: Marianne
authors.initials: M
authors.lastname: Abifadel
authors.forename: Youmna
authors.initials: Y
authors.lastname: Ghaleb
authors.forename: Sandy
authors.initials: S
authors.lastname: Elbitar
authors.forename: Petra
authors.initials: P
authors.lastname: El Khoury
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Rabès
authors.forename: Mathilde
authors.initials: M
authors.lastname: Varret
authors.forename: Catherine
authors.initials: C
authors.lastname: Boileau
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D015316:Genetic Therapy; D006801:Humans; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000276:immunology*; D034741:RNA, Small Interfering / Q000627:therapeutic use; D012697:Serine Endopeptidases / Q000235:genetics / Q000276:immunology*; D035703:Therapies, Investigational / Q000379:methods / Q000639:trends
chemical_list: D000911:Antibodies, Monoclonal; D034741:RNA, Small Interfering; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases